The Clinical Protocol Scientific Review and Monitoring System (CPSRMS) of the Robert H. Lurie Comprehensive Cancer Center (Cancer Center) is composed of several key committees including the Clinical Protocol Scientific Review and Monitoring Committee (CPSRMC), Data Monitoring Committee (DMC), and the Audit Committee. The CPSRMC is charged with the responsibility of evaluating all new and ongoing clinical research protocols for scientific merit and institutional priority. This is required for all studies that have not received review and approval from an NCI-approved external peer review group. The CPSRMC is a multidisciplinary committee that consists of a core group providing the necessary expertise in the principal disciplines of clinical oncology with additional representation from Biostatistics, Laboratory Science, Pharmacy, and Nursing. The CPSRMC is directly responsible for: 1) reviewing new clinical trials to ensure that they are scientifically sound, 2) ensuring study priority has been assigned appropriately by the study Principal Investigator, 3) confirming that the clinical trials are relevant to the goals of the Cancer Center, 4) reviewing for adequacy of data and safety monitoring plans for each new protocol, 5) reviewing and approving all letters of intent prior to development of a local investigator-initiated clinical trial, and 6) reviewing and approving protocol amendments prior to IRB submission. The CPSRMS delegates responsibility for data and safety monitoring of clinical trials to the DMC and Audit Committee, whose activities are described in more detail in section 12.0, Data and Safety Monitoring.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northwestern University at Chicago
United States
Zip Code
Zhao, J C; Fong, K-W; Jin, H-J et al. (2016) FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression. Oncogene 35:4335-44
Kaluzny, Joel; Purta, Patryk; Poskin, Zach et al. (2016) Ex Vivo Confocal Spectroscopy of Autofluorescence in Age-Related Macular Degeneration. PLoS One 11:e0162869
Marsh, Erica E; Chibber, Shani; Wu, Ju et al. (2016) Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma. Fertil Steril 105:1070-5
Zhao, Baobing; Mei, Yang; Schipma, Matthew J et al. (2016) Nuclear Condensation during Mouse Erythropoiesis Requires Caspase-3-Mediated Nuclear Opening. Dev Cell 36:498-510
Ridge, Karen M; Shumaker, Dale; Robert, Amélie et al. (2016) Methods for Determining the Cellular Functions of Vimentin Intermediate Filaments. Methods Enzymol 568:389-426
White, Sarah Beth; Procissi, Daniele; Chen, Jeane et al. (2016) Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases. PLoS One 11:e0155334
Cohee, Andrea A; Stump, Timothy; Adams, Rebecca N et al. (2016) Factors associated with depressive symptoms in young long-term breast cancer survivors. Qual Life Res 25:1991-7
Isabella, Adam J; Horne-Badovinac, Sally (2016) Rab10-Mediated Secretion Synergizes with Tissue Movement to Build a Polarized Basement Membrane Architecture for Organ Morphogenesis. Dev Cell 38:47-60
Valdovinos, Cristina; Penedo, Frank J; Isasi, Carmen R et al. (2016) Perceived discrimination and cancer screening behaviors in US Hispanics: the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study. Cancer Causes Control 27:27-37
Quinn, Gwendolyn P; Woodruff, Teresa K; Knapp, Caprice A et al. (2016) Expanding the Oncofertility Workforce: Training Allied Health Professionals to Improve Health Outcomes for Adolescents and Young Adults. J Adolesc Young Adult Oncol 5:292-6

Showing the most recent 10 out of 1027 publications